Results 141 to 150 of about 191,476 (314)

Research in Solid Dosage Forms-An Obsolete Topic? [PDF]

, 1997
Hans Leuenberger
openalex   +1 more source

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher, Dominika Stastna, Ingrid Menkyova, Vaclav Capek, Jiri Lindner, Petra Nytrova, Jan Krasensky, Eliza Varju, Miguel D'haeseleer, Eva Kubala Havrdova, Dana Horakova, Manuela Vaneckova, Niels Bergsland   +12 more
wiley   +1 more source

Novel Soft Dosage Forms for Paediatric Applications: Can We 3D-Print Them or Not? [PDF]

Gels
Białek A, Krysztofiak J, Hozakowska A, Wojszel Z, Osmałek T, Wojtyłko M, Froelich A.   +6 more
europepmc   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source

Feasibility of Hot Melt Extrusion in Converting Water-Based Nanosuspensions into Solid Dosage Forms. [PDF]

Pharmaceutics
Ragucci E, Uboldi M, Sobczuk A, Facchetti G, Melocchi A, Serratoni M, Zema L.   +6 more
europepmc   +1 more source

Investigation of rectal dosage form of thiamylal sodium.

, 1987
SHOTARO SAKURAI, SHIGERU YAKOU, MASAYASU SUGIHARA   +2 more
openalex   +2 more sources

Guest Editor’s Note: Practical and Regulatory Issues on New Drug, New Dosage Form, and Generic Drug Development [PDF]

, 1997
Oliver Yoa‐Pu Hu, Shein‐Chung Chow
openalex   +1 more source

Interdependence of Dosage Form Microstructure and Performance [PDF]

Pharmaceutical Research, 2017
J. Axel Zeitler, Thomas Rades
openaire   +5 more sources

Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical outcome measures for autoimmune encephalitis (AE) are not yet well defined. Cognitive outcome measures (CogOs) and patient‐reported outcomes (PROs) may capture the symptoms of AE, beyond clinician‐reported outcomes (ClinROs) (the Modified Rankin Scale [mRS] and Clinical Assessment Scale in Autoimmune Encephalitis [CASE ...
Tatchaporn Ongphichetmetha, Carol Swetlik, Nicolas Thompson, Albert Aboseif, Vineet Punia, Brittany Lapin, Jeffrey A. Cohen, Rachel Galioto, Amy Kunchok   +8 more
wiley   +1 more source

Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting. [PDF]

BMC Ophthalmol
Zhao T, Zheng L, Feng Y, Lao M, Huang Y, Wu G.   +5 more
europepmc   +1 more source